The data presented at the Type A meeting in September 2023 appears to have changed that:
- CRL in August (data via targeted, controlled study)
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02694227-3A622780
- Type A announcement in September (data via new potency assay)
https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02714514-3A626594
- Annual Report to Shareholders in October (confirmation: data via potency assay or clinical data)
https://www.mesoblast.com/images/pdf/MSB_2023_Annual_Report_Online.pdf
banter and General Discussion, page-8324
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |